The intestinal microbiome: Relationship to type 1 diabetes

Endocrinology and Metabolism Clinics of North America

Volumn 39, Issue 3, 2010, Pages 563-571

  Neu, Josef ^a   Lorca, Graciela ^b   Kingma, Sandra D K ^c   Triplett, Eric W ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Microbes; Microbiome; Type 1 diabetes

Indexed keywords

ANTIBIOTIC AGENT; AUTOANTIBODY; INSULIN; PREBIOTIC AGENT; PROBIOTIC AGENT; VITAMIN D;

ADAPTIVE IMMUNITY; ANTIGEN ANTIBODY REACTION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACTEROIDES; BIFIDOBACTERIUM; CARBOHYDRATE METABOLISM; DIABETOGENESIS; DISEASE COURSE; ENTERITIS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS; MICROBIAL ACTIVITY; MICROBIOME; NONHUMAN; ORGANISMAL INTERACTION; PRIORITY JOURNAL; REVIEW;

EID: 77955756081     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2010.05.008     Document Type: Review

References (36)

1. Knip M., Veijola R., Virtanen S.M., et al. Environmental triggers and determinants of type 1 diabetes. Diabetes 2005, 54(Suppl 2):S125-S136.
2. Vaarala O., Atkinson M.A., Neu J. The perfect storm for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 2008, 57(10):2555-2562.
3. Proal A.D., Albert P.J., Marshall T. Autoimmune disease in the era of the metagenome. Autoimmun Rev 2009, 8(8):677-681.
4. Turnbaugh P.J., Ley R., Hamad Y.M., et al. The human microbiome project. Nature 2007, 449(164):804-810.
5. Goodacre R. Metabolomics of a superorganism. J Nutr 2007, 137(Suppl 1):259S-266S.
6. Bailey M., Haverson K., Inman C., et al. The development of the mucosal immune system pre- and postweaning: balancing regulatory and effector function. Proc Nutr Soc 2005, 64(4):451-457.
7. Björkstén B. Disease outcomes as a consequence of environmental influences on the development of the immune system. Curr Opin Allergy Clin Immunol 2009, 9(3):185-189.
8. Hooper L.V. Bacterial contributions to mammalian gut development. Trends Microbiol 2004, 12(3):129-134.
9. Stappenbeck T.S., Hooper L.V., Gordon J.I. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci U S A 2002, 99(24):15451-15455.
10. Neish A.S. Microbes in gastrointestinal health and disease. Gastroenterology 2009, 136(1):65-80.
11. Turnbaugh P., Gordon J.I. The core gut microbiome, energy balance and obesity. J Physiol 2009, 587(Pt 17):4153-4158.
12. Meddings J.B., Jarand J., Urbanski S.J., et al. Increased gastrointestinal permeability is an early lesion in the spontaneously diabetic BB rat. Am J Physiol 1999, 276:G951-G957.
13. Neu J., Reverte C.M., Mackey A.D., et al. Changes in intestinal morphology and permeability in the biobreeding rat before the onset of type 1 diabetes. J Pediatr Gastroenterol Nutr 2005, 40(5):589-595.
14. Vael C.A., Desager K.B. The importance of the development of the intestinal microbiota in infancy 2009, 21(6):794-800.
15. Huson D.H., Richter D.C., Mitra S., et al. Methods for comparative metagenomics. BMC Bioinformatics 2009, 10(Suppl 1):S12.
16. Raes J., Foerstner K.U., Bork P. Get the most out of your metagenome: computational analysis of environmental sequence data. Curr Opin Microbiol 2007, 10(5):490-498.
17. Relman D.A. New technologies, human-microbe interactions, and the search for previously unrecognized pathogens. J Infect Dis 2002, 186(Suppl 2):S254-S258.
18. Fisher M.M., Triplett E.W. Automated approach for ribosomal intergenic spacer analysis of microbial diversity and its application to freshwater bacterial communities. Appl Environ Microbiol 1999, 65(10):4630-4636.
19. Roesch L.F., Lorca G.L., Casella G., et al. Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model. ISME J 2009, 3(5):536-548.
20. Patterson C.C., Dahlquist G., Soltesz G., et al. Is childhood-onset type I diabetes a wealth-related disease? An ecological analysis of European incidence rates. Diabetologia 2001, 44(Suppl 3):B9-B16.
21. Wen L., Ley R.E., Volchkov P.Y., et al. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 2008, 455:1109-1113.
22. Graham S., Courtois P., Malaisse W.J., et al. Enteropathy precedes type 1 diabetes in the BB rat. Gut 2004, 53(10):1437-1444.
23. Westerholm-Ormio M., Vaarala O., Pihkala P., et al. Immunologic activity in the small intestinal mucosa of pediatric patients with type 1 diabetes. Diabetes 2003, 52(9):2287-2295.
24. Colgan S.P., Resnick M.B., Parkos C.A., et al. IL-4 directly modulates function of a model human intestinal epithelium. J Immunol 1994, 153(5):2122-2129.
25. Bruewer M., Utech M., Ivanov A.I., et al. Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process. FASEB J 2005, 19(8):923-933.
26. Bosi E., Molteni L., Radaelli M.G., et al. Increased intestinal permeability precedes clinical onset of type 1 diabetes. Diabetologia 2006, 49(12):2824-2827.
27. Cario E., Gerken G., Podolsky D.K. For whom the bell tolls!-innate defense mechanisms and survival strategies of the intestinal epithelium against lumenal pathogens. Z Gastroenterol 2002, 40(12):983-990.
28. Brugman S., Klatter F.A., Visser J.T., et al. Antibiotic treatment partially protects against type 1 diabetes in the bio-breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes?. Diabetologia 2006, 49(9):2105-2108.
29. Coombes J.L., Powrie F. Dendritic cells in intestinal immune regulation. Nat Rev Immunol 2008, 8(6):435-446.
30. Round J.L., O'Connell R.M., Mazmanian S.K. Coordination of tolerogenic immune responses by the commensal microbiota. J Autoimmun 2009, 34(3):J220-J225.
31. Calcinaro F.D.S., Marinaro M., Candeloro P., et al. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 2005, 48(8):1565-1575.
32. Samuelsson U., Ludvigsson J. The concentrations of short-chain fatty acids and other microflora-associated characteristics in faeces from children with newly diagnosed type 1 diabetes and control children and their family members. Diabet Med 2004, 21(1):64-67.
33. Roy C.C., Kien C.L., Bouthillier L., et al. Short-chain fatty acids: ready for prime time?. Nutr Clin Pract 2006, 21(4):351-366.
34. Peng L., Li Z.R., Green R.S., et al. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr 2009, 139(9):1619-1625.
35. Zipitis C.S., Akobeng A.K. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child 2008, 93(6):512-517.
36. Kong J., Zhang Z., Musch M.W., et al. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol 2008, 294(1):G208-G216.